Press Release: APEPTICO : Acute Lung Injury Pipeline Review, H1 2016 - 14 Companies & Approx 42 Molecules - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Acute Lung Injury - Pipeline Review, H1 2016" report to their offering. According to 'Acute Lung Injury - Pipeline Review, H1 2016'; Acute Lung Injury pipeline therapeutics constitutes close to 42 molecules, out of which approximately 32 molecules are developed by Companies and the remaining by Universities/Institutes. Furthermore, the publisher says; Acute Lung Injury Acute lung injury (ALI) is a common condition